Company intelligence / Profile preview
EVER Pharma
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
Overview
EVER Pharma has a broad commercial portfolio with proprietary and value-added injectable products in neurology and specialty injectables. The company emphasizes innovative delivery devices and complex sterile formulations. Clinical results are not detailed publicly but the company markets approved products globally.
- Therapeutic areas
- EndocrinologyNeurologyOncologyOther
- Modalities
- Small moleculeBiologicInjectable formulations
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on EVER Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EVER Pharma.